Towards epigenetic regulation of triple-negative breast cancer via ligand-mediated nanoparticles.
Guilherme F PichethGabriela C CardosoMichelle B ColliniJoão Oc FilizzolaLeonardo B ColautoGiovana G NunesCleverton L PirichThiago Alessandre da SilvaFlávia Ld PontesIngrid F ZattoniEdneia Asr CavalieriGiseli KlassenPublished in: Nanomedicine (London, England) (2023)
Aims: Develop and analyze triple-negative breast cancer targeted nanoparticles loaded with the demethylating agent decitabine. Materials & methods: The polymers were synthesized by ring-opening polymerization of D,l-lactide and formulated into nanoparticles via emulsion-evaporation method. The nanoparticles were characterized by physicochemical analysis as well as in vitro using breast cancer cell lineages. Results & conclusion: The targeted nanoparticles exhibited a hydrodynamic diameter of 75 ± 12 nm, zeta potential -6.3 ± 0.2 mV and spherical morphology, and displayed greater in vitro accumulation into MDA-MB-231 (triple-negative breast cancer cell-line) compared with MCF7 and HB4A cell lineages as verified by fluorescence confocal microscopy and significant demethylating effects via ADAM33 screening by PCR.